beta

ACST

Acasti Pharma, Inc.

Acst

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Market Cap: 174 Million

Primary Exchange: NASDAQ

Website: http://www.acastipharma.com

Shares Outstanding: 85.3 Million

Float: 67.8 Million

Dividend: (%)

Beta: 1.042020809482

Sector: Health Technology

Industry: Pharmaceuticals: Other

Ethical Flags

Animal testing

Longest drawdown: 1611 trading days

From: 2013-08-05 To: 2019-12-13

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-10-15 10.0 1.0 10.0
Data provided by IEX Cloud